Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.110
-0.060 (-1.89%)
At close: Mar 20, 2026, 4:00 PM EDT
3.190
+0.080 (2.57%)
After-hours: Mar 20, 2026, 7:59 PM EDT
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $829.96 million as of March 20, 2026. Its market cap has increased by 45.78% in one year.
Market Cap
829.96M
Enterprise Value
777.84M
1-Year Change
45.78%
Ranking
Category
Stock Price
$3.11
Market Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $829.96M, a decrease of -37.36%. That is a compound annual growth rate of -8.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 829.96M | -23.44% |
| Dec 31, 2025 | 1.08B | 197.89% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GH Research | 866.55M |
| SpyGlass Pharma | 866.25M |
| KalVista Pharmaceuticals | 859.29M |
| UroGen Pharma | 857.78M |
| Janux Therapeutics | 855.29M |
| SELLAS Life Sciences Group | 854.81M |
| Evommune | 840.31M |
| Adlai Nortye | 819.19M |